Budget Amount *help |
¥3,640,000 (Direct Cost: ¥2,800,000、Indirect Cost: ¥840,000)
Fiscal Year 2013: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
Fiscal Year 2012: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
|
Research Abstract |
To evaluate the utility of basic fibroblast growth factor (bFGF) for the treatment of hypertrophic scar, we investigated the effects on cultured fibroblasts of bFGF. On the basis of the findings that dermal fibroblast is mixed population consisted of some subpopulations having differing characteristics, superficial fibroblasts, which express anti-fibrotic factors, and deep fibroblasts, which express pro-fibrotic factors, were isolated and analysed by microarray and real-time PCR. Basic FGF were elucidated to increase the expression of specific factor for superficial fibroblasts, suggesting enhance the capability of the cells to suppress fibrosis.
|